The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/ lpr Mice
Open accessAbstract
We have previously reported that IL-10+ regulatory B cells, known to play an important role in controlling autoimmunity and inflammatory disorders, are contained within the transitional 2 immature (T2) B cell pool (T2 Bregs). Therapeutic strategies facilitating their enrichment or enhancing their suppressive activity are highly attractive. In this study, we report that agonistic anti-CD40 specifically targets T2 B cells and enriches Bregs upon short-term in vitro culture. Although transfer of unmanipulated T2 B cells, isolated from mice with established lupus, failed to confer protection to diseased mice, transfer of in vitro anti-CD40-generated T2 B cells (T2-like-Bregs) significantly improved renal disease and survival by an IL-10-dependent mechanism. T2-like-Bregs readily accumulated in the spleen after transfer, suppressed Th1 responses, induced the differentiation of IL-10+CD4+T cells, and conveyed a regulatory effect to CD4+T cells. In addition, in vivo administration of agonistic anti-CD40, currently on trial for the treatment of cancer, halted and reversed established lupus. Taken together, our results suggest a novel cellular approach for the amelioration of experimental lupus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2016) · Diagnostic Imaging: Brain · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Rahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,632
Self-citationAsseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,615
Yanaba, K., Bouaziz, J.-D., Haas, K. M., Poe, J. C., Fujimoto, M., & Tedder, T. F. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.017 · Cited by 1,238
Rahman, M. U. (2008) · Essentials of Physical Medicine and Rehabilitation · doi:10.1016/b978-1-4160-4007-1.50153-x · Cited by 1,019
Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S., & Bhan, A. K. (2002) · Immunity · doi:10.1016/s1074-7613(02)00274-1 · Cited by 978
Loder, B. F., Mutschler, B., Ray, R. J., Paige, C. J., Sideras, P., Torres, R., Lamers, M. C., & Carsetti, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.1.75 · Cited by 863
Prevention of Arthritis by Interleukin 10–producing B Cells
Mauri, C., Gray, D., Mushtaq, N., & Londei, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021293 · Cited by 860
Self-citationAwasthi, A., Carrier, Y., Peron, J. P. S., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., & Weiner, H. L. (2007) · Nature Immunology · doi:10.1038/ni1541 · Cited by 804
Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis
Evans, J. G., Chavez-Rueda, K. A., Eddaoudi, A., Meyer-Bahlburg, A., Rawlings, D. J., Ehrenstein, M. R., & Mauri, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7868 · Cited by 570
Self-citationLeandro, M. J., Cambridge, G., Ehrenstein, M. R., & Edwards, J. C. W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21617 · Cited by 560
Self-citationAllman, D., Lindsley, R. C., DeMuth, W., Rudd, K., Shinton, S. A., & Hardy, R. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.6834 · Cited by 552
Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells
Levings, M. K., Gregori, S., Tresoldi, E., Cazzaniga, S., Bonini, C., & Roncarolo, M. G. (2005) · Blood · doi:10.1182/blood-2004-03-1211 · Cited by 483
Peripheral development of B cells in mouse and man
Carsetti, R., Rosado, M. M., & Wardmann, H. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0109.x · Cited by 473
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice
Hu, C.-Y., Rodriguez-Pinto, D., Du, W., Ahuja, A., Henegariu, O., Wong, F. S., Shlomchik, M. J., & Wen, L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32405 · Cited by 426
Self-citationApoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells
Gray, M., Miles, K., Salter, D., Gray, D., & Savill, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700326104 · Cited by 327
TLR‐mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells
Barr, T. A., Brown, S., Ryan, G., Zhao, J., & Gray, D. (2007) · European Journal of Immunology · doi:10.1002/eji.200636483 · Cited by 281
The central and multiple roles of B cells in lupus pathogenesis
Chan, O. T. M., Madaio, M. R., Shlomchik, M. J., Chan, O. I. M., Madaio, M. P., & Shlomchik, M. J. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01310.x · Cited by 281
Self-citationThe ‘short’ history of regulatory B cells
Mauri, C., & Ehrenstein, M. R. (2008) · Trends in Immunology · doi:10.1016/j.it.2007.10.004 · Cited by 280
Self-citationDepletion of B Cells in Murine Lupus: Efficacy and Resistance
Ahuja, A., Shupe, J., Dunn, R., Kashgarian, M., Kehry, M. R., & Shlomchik, M. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3351 · Cited by 239
Self-citationYin, Z., Bahtiyar, G., Zhang, N., Liu, L., Zhu, P., Robert, M. E., McNiff, J., Madaio, M. P., & Craft, J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2148 · Cited by 227
Su, T. T., & Rawlings, D. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2101 · Cited by 223
Regulatory role of mature B cells in a murine model of inflammatory bowel disease
Mizoguchi, E., Mizoguchi, A., Preffer, F. I., & Bhan, A. K. (2000) · International Immunology · doi:10.1093/intimm/12.5.597 · Cited by 206
IL-17 and the Th17 lineage in systemic lupus erythematosus
Garrett‐Sinha, L. A., John, S. A., & Gaffen, S. L. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328304b6b5 · Cited by 153
Type I interferons protect neonates from acute inflammation through interleukin 10–producing B cells
Zhang, X., Deriaud, E., Jiao, X., Braun, D., Leclerc, C., & Lo-Man, R. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062013 · Cited by 150
Signaling in transitional type 2 B cells is critical for peripheral B‐cell development
Su, T. T., Guo, B., Wei, B., Braun, J. G., & Rawlings, D. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0102.x · Cited by 133
What does the future hold for cell-based tolerogenic therapy?
Bluestone, J. A., Thomson, A. W., Shevach, E. M., et al. (2007) · Nature reviews. Immunology · doi:10.1038/nri2137 · Cited by 133
Mauri, C., Mars, L. T., & Londei, M. (2000) · Nature Medicine · doi:10.1038/76251 · Cited by 120
Self-citationBone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy
Leandro, M. J., Cooper, N., Cambridge, G., Ehrenstein, M. R., & Edwards, J. (2006) · Rheumatology · doi:10.1093/rheumatology/kel148 · Cited by 100
Self-citationSater, R. A. (1998) · International Immunology · doi:10.1093/intimm/10.11.1673 · Cited by 89
Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions
Miyashita, T., McIlraith, M., Grammer, A. C., Miura, Y., Attrep, J. F., Shimaoka, Y., & Lipsky, P. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4620 · Cited by 82
Mauri, C., Chu, C., Woodrow, D. F., Mori, L., & Londei, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.5032 · Cited by 58
Self-citationKin, N. W., Crawford, D., Liu, J., Behrens, T. W., & Kearney, J. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6663 · Cited by 52
Characterization of B-Cell Maturation in the Peripheral Immune System
Carsetti, R. (2004) · Humana Press eBooks · doi:10.1385/1-59259-796-3:025 · Cited by 29
Combination antibody‐based cancer immunotherapy
Takeda, K., Okumura, K., & Smyth, M. J. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00529.x · Cited by 20
Antigen receptor-mediated signaling pathways in transitional immature B cells
Kövesdi, D., Pászty, K., Enyedi, Á., Kiss, E., Matkó, J., Ludányi, K., Rajnavölgyi, É., & Sármay, G. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.01.005 · Cited by 17
Cited by
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
Self-citationRegulatory B Cells: Origin, Phenotype, and Function
Rosser, E. C., & Mauri, C. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.005 · Cited by 1,455
Self-citationImmune Regulatory Function of B Cells
Mauri, C., & Bosma, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074934 · Cited by 1,249
Self-citationGuidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Flores-Borja, F., Bosma, A., Ng, D., Reddy, V., Ehrenstein, M. R., Isenberg, D. A., & Mauri, C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005407 · Cited by 688
Self-citation
Metadata
- Authors
- Blair, P. A., Chavez-Rueda, K. A., Evans, J. G., Shlomchik, M. J., Eddaoudi, A., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03
- Volume
- 182
- Issue
- 6
- Pages
- 3492-3502
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1882149925
- Cited by
- 291
- References
- 37
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.